Apoptotic cell death in disease—Current understanding of the NCCD 2023

I Vitale, F Pietrocola, E Guilbaud… - Cell Death & …, 2023 - nature.com
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase
family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis …

[HTML][HTML] Pharmacological effects and mechanisms of tannic acid

W Jing, C Xiaolan, C Yu, Q Feng, Y Haifeng - Biomedicine & …, 2022 - Elsevier
In recent years, increasing attention has been paid to the pharmacological efficacy of
tannins. Tannic acid (TA), the simplest hydrolysable tannin that has been approved by the …

[HTML][HTML] Multi-organ proteomic landscape of COVID-19 autopsies

X Nie, L Qian, R Sun, B Huang, X Dong, Q Xiao… - Cell, 2021 - cell.com
The molecular pathology of multi-organ injuries in COVID-19 patients remains unclear,
preventing effective therapeutics development. Here, we report a proteomic analysis of 144 …

Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis

THG Phan, P Paliogiannis, GK Nasrallah… - Cellular and Molecular …, 2021 - Springer
Idiopathic pulmonary fibrosis (IPF), the most common form of idiopathic interstitial
pneumonia, is a progressive, irreversible, and typically lethal disease characterized by an …

TGF-β1 signaling and tissue fibrosis

KK Kim, D Sheppard… - Cold Spring Harbor …, 2018 - cshperspectives.cshlp.org
Activation of TGF-β1 initiates a program of temporary collagen accumulation important to
wound repair in many organs. However, the outcome of temporary extracellular matrix …

Resolution of organ fibrosis

JI Jun, LF Lau - The Journal of clinical investigation, 2018 - Am Soc Clin Investig
Fibrosis is the excessive accumulation of extracellular matrix that often occurs as a wound
healing response to repeated or chronic tissue injury, and may lead to the disruption of …

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis

VJ Craig, L Zhang, JS Hagood… - American journal of …, 2015 - atsjournals.org
Idiopathic pulmonary fibrosis (IPF) is a restrictive lung disease that is associated with high
morbidity and mortality. Current medical therapies are not fully effective at limiting mortality …

Diverse functions of matrix metalloproteinases during fibrosis

M Giannandrea, WC Parks - Disease models & mechanisms, 2014 - journals.biologists.com
Fibrosis–a debilitating condition that can occur in most organs–is characterized by excess
deposition of a collagen-rich extracellular matrix (ECM). At first sight, the activities of …

Therapy for fibrotic diseases: nearing the starting line

SL Friedman, D Sheppard, JS Duffield… - Science translational …, 2013 - science.org
Fibrosis, or the accumulation of extracellular matrix molecules that make up scar tissue, is a
common feature of chronic tissue injury. Pulmonary fibrosis, renal fibrosis, and hepatic …

Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: EMMPRIN/CD147 comes into play

L Chuliá-Peris, C Carreres-Rey, M Gabasa… - International journal of …, 2022 - mdpi.com
Pulmonary fibrosis (PF) is characterized by aberrant extracellular matrix (ECM) deposition,
activation of fibroblasts to myofibroblasts and parenchymal disorganization, which have an …